Obesity

Showing NaN - NaN of 95

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity Trial in Nashville (Pentoxifylline, Placebo)

Completed
  • Obesity
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Oct 24, 2017

Physical Activity, Weight and Fitness Outcomes in After-Care

Completed
  • Obesity
  • Exercise
    • Nashville, Tennessee
    • +1 more
    Nov 2, 2017

    Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )

    Completed
    • Metabolism and Nutrition Disorder
    • Obesity
    • Goodyear, Arizona
    • +36 more
    Sep 29, 2017

    Obesity Trial in Nashville (Bradykinin)

    Terminated
    • Obesity
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jul 13, 2017

    Obesity Trial in Nashville (radiation, procedure, behavioral, other)

    Completed
    • Obesity
    • PET scan
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Mar 29, 2017

    Metabolic Syndrome, Obesity Trial in Nashville (Sildenafil, Placebo)

    Completed
    • Metabolic Syndrome
    • Obesity
    • Nashville, Tennessee
      Vanderbilt University
    Feb 22, 2017

    Obesity, Overweight, Craniopharyngioma Trial in Nashville (Exenatide)

    Completed
    • Obesity
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University
    Jan 17, 2017

    Obesity Trial in Nashville (omentectomy)

    Completed
    • Obesity
    • omentectomy
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jan 30, 2017

    Prader-Willi Syndrome, Obesity Trial in United States (ZGN-440 for Injectable Suspension, ZGN-440 Placebo for Injectable

    Terminated
    • Prader-Willi Syndrome
    • Obesity
    • ZGN-440 for Injectable Suspension
    • ZGN-440 Placebo for Injectable Suspension
    • Sacramento, California
    • +14 more
    Jan 24, 2017

    Factors Involved in Obesity-related Inflammation and Insulin

    Terminated
    • Obesity
    • +2 more
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jan 19, 2017

      Obesity, Insulin Resistance, Normal Weight,Healthy Controls Trial in Nashville (Ghrelin infusion to assess effects on insulin

      Completed
      • Obesity
      • +2 more
      • Ghrelin infusion to assess effects on insulin sensitivity
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jan 18, 2017

      Obesity, Hypertension Trial in Nashville (L-NMMA, Trimethaphan)

      Completed
      • Obesity
      • Hypertension
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Jan 16, 2017

      CD36 Deficiency in African Americans

      Completed
      • Obesity
        • Nashville, Tennessee
          Vanderbilt University
        Dec 29, 2016

        Obesity Trial in Nashville (Cytokines assessed from fat tissue)

        Completed
        • Obesity
        • Cytokines assessed from fat tissue
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        Nov 17, 2016

        Obesity Trial in Nashville (Blocked, Intact)

        Completed
        • Obesity
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        Jul 6, 2016

        Obesity, Over-weight, Hypothalamic Injury Trial in Australia, United States (ZGN-440 sterile diluent, ZGN-440 for injectable

        Completed
        • Obesity
        • +3 more
        • ZGN-440 sterile diluent
        • ZGN-440 for injectable suspension
        • St. Paul, Minnesota
        • +3 more
        Jul 14, 2016

        Obesity Trial in Davidson, Nashville (Different levels of cost sharing)

        Completed
        • Obesity
        • Different levels of cost sharing
        • Davidson, North Carolina
        • +1 more
        Dec 18, 2015

        Type 2 Diabetes, Exercise, Obesity Trial in Nashville (Behavioral counseling plus "telephone helpline")

        Terminated
        • Type 2 Diabetes Mellitus
        • +3 more
        • Behavioral counseling plus "telephone helpline"
        • Nashville, Tennessee
          Vanderbilt University Medical Center
        May 21, 2015

        Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)

        Completed
        • Obesity
        • Placebo
        • Pramlintide and Metreleptin
        • Birmingham, Alabama
        • +32 more
        Mar 26, 2015

        Overweight, Obesity Trial in United States (pramlintide acetate, metreleptin, -P)

        Completed
        • Overweight
        • Obesity
        • pramlintide acetate
        • +3 more
        • Birmingham, Alabama
        • +35 more
        Mar 26, 2015

        Obesity, Overweight, Diabetes, Type 2 Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/ day, Placebo, Ancillary

        Completed
        • Obesity
        • +2 more
        • Naltrexone SR 32 mg/bupropion SR 360 mg/ day
        • +2 more
        • Fairhope, Alabama
        • +52 more
        Nov 18, 2014

        Obesity, Overweight Trial in United States (Naltrexone SR 32 mg/bupropion SR 360 mg/day, Placebo, Ancillary therapy)

        Completed
        • Obesity
        • Overweight
        • Naltrexone SR 32 mg/bupropion SR 360 mg/day
        • +2 more
        • Phoenix, Arizona
        • +35 more
        Nov 18, 2014

        Prader-Willi Syndrome and Early-onset Morbid Obesity

        Completed
        • Prader-Willi Syndrome
        • Obesity
        • Group 1
        • Group 2
        • Orange, California
        • +3 more
        Sep 18, 2014

        Diabetes, Obesity Trial in Nashville (Lifestyle counseling)

        Completed
        • Diabetes
        • Obesity
        • Lifestyle counseling
        • Nashville, Tennessee
          Coleman Community Recreation Center
        Dec 17, 2013